Medical Adhesive Incorporating Cationic Steroidal Antimicrobials ID: 2024-057
A groundbreaking adhesive that combines healing and antimicrobial properties for medical applications.
Photo by starlineart - stock.adobe.com
Technology Overview
This invention presents a novel medical adhesive that integrates cationic steroidal antimicrobials, designed to not only close wounds but also prevent infection. The confidential invention disclosure form from BYU Technology Transfer outlines the process for documenting, patenting, and potentially commercializing this innovative technology.
Key Advantages
- Enhanced wound healing capabilities
- Significant antimicrobial properties to prevent infections
- Reduced risk of antibiotic resistance due to the use of steroidal antimicrobials
- Potential for broader application in various medical settings
Problems Addressed
- Prevention of wound infections without relying on traditional antibiotics
- Improvement in the healing process of wounds with a single application
- Addresses the challenge of antibiotic resistance in wound management
Market Applications
- Hospitals and clinics for post-surgical wound care
- Emergency medical services for immediate wound treatment and infection control
- Chronic wound management for patients with diabetes or other conditions leading to slow healing
- Military medical applications for field treatment of injuries
Additional Information
Technology ID: 2024-057
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 07 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report